Skip to main content
Jeffrey Laurence, MD, Oncology, New York, NY, New York-Presbyterian Hospital

JeffreyCLaurenceMD

Oncology • New York, NY

Professor, Medicine, Weill Cornell Medical College

Request Appointment

Overview of Dr. Laurence

Dr. Jeffrey Laurence is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 41 years. Dr. Laurence accepts several types of health insurance, listed below. He is one of 368 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1979 - 1982
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1976 - 1979
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1976

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1977 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1997
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Differential Effects of HIV Protease Inhibitors on Release and Activation of Platelet-Derived TGF-_1: Potential Association with HIV-Linked CVD
    Jeffrey Laurence, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Defibrotide Inhibits Endothelial Cell Injury Induced By Plasmas of Patients with Thrombotic Microangiopathies 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Masp-2 Levels Following Allogeneic Hematopoietic Stem Cell Transplantation in Adults: Correlation with Development of a Thrombotic Microangiopathy and Implications for... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Simple Skin Biopsy Can Assess Tissue Damage Related to COVID-19
    Simple Skin Biopsy Can Assess Tissue Damage Related to COVID-19July 15th, 2022
  • Using Simple Skin Biopsy, Blood Clots Linked to Covid Can Be Evaluated
    Using Simple Skin Biopsy, Blood Clots Linked to Covid Can Be EvaluatedJuly 15th, 2022
  • Covid-19 Patients Benefit from Improved Screening and Treatment of Blood Clots
    Covid-19 Patients Benefit from Improved Screening and Treatment of Blood ClotsDecember 10th, 2021
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    MVP Healthcare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Jeffrey Laurence, Dr. Jeffrey Laurence, MD, Dr. J Laurence, Dr. Jeffrey C Laurence